COMBI PACK ANTI - A, B & D MONOCLONAL(COMBI PACK ANTI - A, B & D MONOCLONAL) - India CDSCO Medical Device Registration

COMBI PACK ANTI - A, B & D MONOCLONAL(COMBI PACK ANTI - A, B & D MONOCLONAL) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000005_86cee78bc00e2b98aabcfe851c5fd751_cc0a65284bee227c38e00ec4316dce5f. This device is marketed under the brand name IgM+IgG. The license holder is Dhiti Diagnostics Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO -North Zone, Ghaziabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

COMBI PACK ANTI - A, B & D MONOCLONAL(COMBI PACK ANTI - A, B & D MONOCLONAL)

UID: MFG/IVD/2022/000005_86cee78bc00e2b98aabcfe851c5fd751_cc0a65284bee227c38e00ec4316dce5f

Brand Name

IgM+IgG

License Holder

Dhiti Diagnostics Private Limited

Device Class

Class D

Approving Authority

CDSCO -North Zone, Ghaziabad

Product Information

The Combi Pack Anti - A, B & D (IgM+IgG) Monoclonal reagent consist of Monoclonal blood grouping Anti-A, Anti-B, and Anti-D (IgM+IgG) reagents. These reagents can be used for in vitro determination of the presence or absence of A, B, D, and DU antigens in red cells of human blood